Request Your 2013 Brochure

Join our priority contact list and receive the latest event news.

New this Year!

• More key opinion leader speakers from China
• Three interactive panel discussions
• 7 talks with case studies/unpublished data
• Early registration/group rates of CNY4000 for China domestic companies

"This conference attracts the best minds in the biotech industry, providing an excellent readout of current status in biologics development." - Xing Wang, Array Bridge

Speaker Interview Podcast

New Speaker Interview Podcast with H. Fai Poon, Ph.D., Director of Cell Culture at Hisun Pharmaceutical (Hangzhou) Co., Ltd., China

Sponsors

Gold Sponsor:

Silver Sponsors:

Presentation Sponsors:

"We thoroughly enjoyed the program this year and are happy to see the event continuing to grow in size and scope." - Bill Whitford, Thermo Fisher

IBC's 5th Annual BioProcess International™ China conference provides you with practical tools, techniques and strategies to improve your upstream and downstream development efforts and offer you insights into state-of-the-art approaches for GMP manufacturing and scale-up that meet international standards.

Keynote Presentations

Large Molecules Present Great Opportunities in China	Manage Supply Risk by Building a Robust Biomanufacturing Network	Anti-Cancer Antibody Development in China
Ge Li, Ph.D.Chairman & CEO WuXi AppTec	Jian Irish, Ph.D.Executive Director, Asia Region General Manager, Manufacturing and Supply Chain, Amgen, Inc.	Yajun Guo, M.D., Ph.D.Professor and Director, Shanghai International Joint Cancer Institute, Shanghai Second Military Medical University

Find Practical Strategies to Accelerate Your Biologics to Market

• More Efficient Cell Line, Cell Culture and Media Development
• New Techniques for Analytical, Quality and Comparability
• State-of the-Art Methods for Biomanufacturing, Facilities & GMP Compliance
• Accelerated IND Filings in China
• Overcome Downstream Processing and Purification Bottlenecks
• Viral Safety for Biologicals to Protect Your Operations
• Compare Data from mAbs, Vaccines, Biosimilars, Fusions and more

Plus ... 3 Interactive Panel Discussions to Share New Ideas, Challenges and Solutions:

• The Commercial and Business Landscape for Biosimilars
• Developing Biologics Partnerships in China
• Biologics Regulation in China Compared to US/Europe

Why You Should Attend

International companies:
This is your gateway to meet and network with Chinese/Asian drug developers and contract manufacturers to understand where they stand in the field of processing capabilities, as well as find potential business partners and collaborators to develop biosimilars, biobetters, novel biologics or vaccines.

China-based companies:
This is your opportunity to learn technical know-how and practical solutions from the experienced scientists and engineers from around the world, as well as hear how to trouble-shoot problems and avoid pitfalls in the quest for higher yield and better quality.

"We thoroughly enjoyed the program this year and are happy to see the event continuing to grow in size and scope." - Bill Whitford, Thermo Fisher

Your Global Industry Resource

Join the Fastest Growing Event Series for Bioprocess Scientists and Engineers

	September 16-19, 2013 Boston, USA			August 20-22, 2013 Shanghai, China			April 17-18, 2013 Düsseldorf, Germany
www.IBCLifeSciences.com/BPI			www.IBCLifeSciences.com/BPIChina			www.bpi-eu.com